Many medical institutions only treat the patient when the industry at large is sick. By considering the techniques and practices that realistically work for people, there is hope to save the healthcare industry and treat how it helps people. Listen in to learn: How to change the user experience in the digital health industry Current […]

Fibrotic diseases such as non-alcoholic steatohepatitis (NASH) – caused by inflammation of the liver by a buildup of fat – currently have no non-invasive methods to monitor treatment response. In order to address this, Glympse Bio has developed activity-based biosensors, designed to detect early signs of disease, predict stage of disease and support the development […]

Affinity Empowering  Chief Behavioral Health Officer and Chief Operating Officer Dr. Michael Tkach studies the linkage between inflammation and depression while pioneering a streamlined and powerful approach to pool testing. Two swabs anyone?